Cora Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cora Capital Advisors's LLY Position: Q3 2026 in Review
Cora Capital Advisors reduced its Eli Lilly (LLY) stake by 0.99% in Q3 2026, selling an estimated $16.5K and leaving 1,406 shares worth $1.63M. The position accounts for 0.43% of the portfolio, ranked #35.
Cora Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.7M in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Cora Capital Advisors held 1,406 shares of Eli Lilly worth $1.63M as of Q3 2026.
- Cora Capital Advisors sold 14 Eli Lilly shares in Q3 2026, an estimated $16.5K.
- Eli Lilly made up 0.43% of Cora Capital Advisors's portfolio in Q3 2026, its #35 holding.
- Cora Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- Cora Capital Advisors's Eli Lilly position peaked at $1.7M in Q2 2026.
- 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Cora Capital Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.